A carregar...
Apolipoprotein E as a Therapeutic Target in Alzheimer’s disease: A Review of Basic Research and Clinical Evidence
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder which causes progressive cognitive decline. The majority of AD cases are sporadic and late-onset (> 65 years old) making it the leading cause of dementia in the elderly. While both genetic and environmental factors contribute to...
Na minha lista:
Publicado no: | CNS Drugs |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5526196/ https://ncbi.nlm.nih.gov/pubmed/27328687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-016-0361-4 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|